Dentin Hypersensitivity Reduction Efficacy Clinical
NCT07738198
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
116
Enrollment
INDUSTRY
Sponsor class
Conditions
Dental Hypersensitivity
Interventions
DRUG:
0.454% stannous fluoride toothpaste
DRUG:
5% potassium nitrate
DRUG:
0.76% sodium monofluorophosphate
Sponsor
Colgate Palmolive